Skip to main content

Glossary

TermDefinition
NMRANational Medicines Regulatory Authority — Sri Lanka's regulatory body for medicines, devices, and related products
NMRA ActNMRA Act No. 5 of 2015 — the primary legislation establishing NMRA and its powers
MAHMarketing Authorization Holder — Sri Lanka-based entity with full regulatory accountability for a registered device
MDECMedical Devices Evaluation Committee — expert advisory body reviewing Class IIb/III applications
Registration CertificateStep 1 approval — confirms device meets NMRA safety and performance requirements
Import LicenceStep 2 approval — authorises commercial importation of a registered device
Sample Import LicenceTemporary permit to import samples required for registration (e.g., for local testing)
F-MDR-035NMRA's Consolidated Dossier Submission Checklist — mandatory format for all new device registration applications
Consolidated DossierSingle all-in-one submission package covering all registration requirements, per F-MDR-035
Reliance PathwayFast-track registration pathway leveraging prior approval from accepted reference countries (from Oct 2025)
SMFSite Master File — manufacturing facility documentation submitted for NMRA site registration
SRAStringent Regulatory Authority — reference country regulator (FDA, TGA, MHRA, EMA, etc.)
WHO PQWorld Health Organization Pre-Qualification — alternative route for NMRA audit waiver
GDPMDGood Distribution Practice of Medical Devices — distribution quality standards
FSCAField Safety Corrective Action — action to reduce risk from a marketed device
FSNField Safety Notice — user communication issued in connection with an FSCA
PSURPeriodic Safety Update Report — systematic post-market safety summary
PMCFPost-Market Clinical Follow-Up — post-registration clinical data collection
AEAAtomic Energy Authority of Sri Lanka — separate approving body for radiation-emitting devices
USD rateNMRA annual fees are denominated in USD; converted to LKR at the rate published monthly on the NMRA website